1. Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M (2012) Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 13(6):622–632. doi: 10.1016/S1470-2045(12)70121-3
2. Smith DW, Stoimenova D, Eid K, Barqawi A (2012) The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges. Prostate Cancer 2012:587139. doi: 10.1155/2012/587139
3. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, Koga F, Masuda H, Kawakami S, Fujii Y, Kihara K (2012) Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. doi: 10.1016/j.eururo.2012.10.010
4. Numao N, Yoshida S, Komai Y, Ishii C, Kagawa M, Kijima T, Yokoyama M, Ishioka J, Matsuoka Y, Koga F, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K (2013) Usefulness of prebiopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer. J Urol. doi: 10.1016/j.juro.2013.02.3197
5. Tan CH, Wang J, Kundra V (2011) Diffusion weighted imaging in prostate cancer. Eur Radiol 21(3):593–603. doi: 10.1007/s00330-010-1960-y